Rankings
▼
Calendar
CLYM (Climb Bio, Inc.) Stock Financials & Earnings | Market Cap Arena
CLYM
Climb Bio, Inc.
Mkt Cap
$522M
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
-$60M
EPS (TTM)
-$0.89
Free Cash Flow (TTM)
-$55M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Next: Q1 2026 · Mar 24
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$23M
Q2 23
$0
$0
-$7M
Q3 23
$0
$0
-$5M
Q4 23
$0
$0
-$5M
Q1 24
$0
$0
-$3M
Q2 24
$0
$0
-$56M
Q3 24
$0
$0
-$12M
Q4 24
$0
$0
-$11M
Q1 25
$0
$0
-$23M
Q2 25
$0
-$38K
-$11M
Q3 25
$0
$0
-$15M
Q4 25
$0
-$30K
-$19M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$15M
-$15M
Q2 23
-$8M
-$8M
Q3 23
$3M
$3M
Q4 23
-$947K
-$947K
Q1 24
-$2M
-$2M
Q2 24
-$667K
-$667K
Q3 24
-$8M
-$8M
Q4 24
-$6M
-$6M
Q1 25
-$15M
-$15M
Q2 25
-$11M
-$11M
Q3 25
-$12M
-$12M
Q4 25
-$16M
-$16M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$0
Q1 24
$0
Q2 24
$0
Q3 24
$0
Q4 24
$0
Q1 25
$0
Q2 25
$77K
Q3 25
$109K
Q4 25
$0
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+78.5%
Q2 23
—
-51.0%
Q3 23
—
-42.8%
Q4 23
—
-46.4%
Q1 24
—
-87.2%
Q2 24
—
+739.6%
Q3 24
—
+134.6%
Q4 24
—
+113.0%
Q1 25
—
+666.0%
Q2 25
—
-81.1%
Q3 25
—
+26.9%
Q4 25
—
+76.8%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$10M
—
Q2 23
$777K
—
Q3 23
$656K
—
Q4 23
$1M
—
Q1 24
$465K
—
Q2 24
$512K
—
Q3 24
$3M
—
Q4 24
$2M
—
Q1 25
$2M
—
Q2 25
$1M
—
Q3 25
$4M
—
Q4 25
$0
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
SG&A
Quarter
R&D
G&A
SG&A
Q1 23
$6M
$18M
—
Q2 23
$4M
$3M
—
Q3 23
$3M
$2M
—
Q4 23
$3M
$2M
—
Q1 24
$1M
$2M
—
Q2 24
$53M
$4M
—
Q3 24
$6M
$5M
—
Q4 24
$6M
$5M
—
Q1 25
$17M
$6M
—
Q2 25
$7M
$4M
—
Q3 25
$9M
$6M
—
Q4 25
$14M
—
$6M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$34M
$75M
$109M
Q2 23
$25M
$77M
$103M
Q3 23
$57M
$50M
$107M
Q4 23
$93M
$14M
$107M
Q1 24
$105M
$0
$105M
Q2 24
$223M
$0
$223M
Q3 24
$146M
$47M
$193M
Q4 24
$87M
$64M
$151M
Q1 25
$29M
$69M
$98M
Q2 25
$23M
$62M
$85M
Q3 25
$26M
$61M
$87M
Q4 25
$36M
$65M
$101M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
27M
+0.6%
Q2 23
27M
+1.1%
Q3 23
27M
+0.9%
Q4 23
27M
+0.9%
Q1 24
28M
+1.2%
Q2 24
30M
+9.8%
Q3 24
67M
+120.8%
Q4 24
65M
-3.4%
Q1 25
67M
+4.2%
Q2 25
68M
+0.2%
Q3 25
68M
+0.6%
Q4 25
67M
-0.9%
marketcaparena.com